HAEE and derivatives for proposed endogenous HAEE deficiency — RU2841374C1
Sergey A. Kozin, Artur T. Kopylov, Ruslan Y. Yakovlev, Evgeny V. Myachin · 2025 · RU2841374C1 · patent family RU2841374C1
Published 2025-06-06.
Reported patent results
Reported findings
The patent reports about twice the endogenous HAEE concentration in the active groups as in saline controls, alongside behavioral differences (Tables 2–3).
A rat stroke example enrolled 80 rats before surgery, reported 23 survivors on day 10 and formed four groups of five. The patent describes eight intraperitoneal injections of 0.3 mg/kg HAEE equivalent or saline.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Endogenous HAEE at day 30 | The patent reports about twice the endogenous HAEE concentration in the active groups as in saline controls, alongside behavioral differences (Tables 2–3). |
This is a small post-stroke rat experiment among selected survivors. The filing does not establish an Alzheimer’s treatment effect.
Source for these results ↗ · Reviewed 2026-11-12
Patent claims and provenance
Use. Claims HAEE, salts and complexes for conditions the filing associates with lower endogenous HAEE.
This is a small post-stroke rat experiment among selected survivors. The filing does not establish an Alzheimer’s treatment effect.
- Publication
- RU2841374C1 ↗ · 2025-06-06
- Earliest priority / filing
- 2025-03-14 / 2025-03-14
- Original applicant / assignee
- Sergey A. Kozin
- Indexed status
- Not shown; official status unverified · checked 2026-11-12
- Patent family
- Grouping identifier unavailable · family publications are related filings, not independent studies.
Original title, inventors and related publications
HAEE and derivatives for proposed endogenous HAEE deficiency
Inventors: Sergey A. Kozin; Artur T. Kopylov; Ruslan Y. Yakovlev; Evgeny V. Myachin.
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- This is a small post-stroke rat experiment among selected survivors. The filing does not establish an Alzheimer’s treatment effect.
- This is a small post-stroke rat experiment among selected survivors. The filing does not establish an Alzheimer’s treatment effect.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; each record lists the review date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Available format: Original patent text and indexed metadata
Material reviewed: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related publications may cover the same research program or participants.
Source access
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Source reviewed 2026-11-12.
Source type: Patent publication
Citation and original source
Original source: Sergey A. Kozin, Artur T. Kopylov, Ruslan Y. Yakovlev, Evgeny V. Myachin. HAEE and derivatives for proposed endogenous HAEE deficiency — RU2841374C1 RU2841374C1 · patent family RU2841374C1 2025.
Molekul research summary: https://molekul.io/research/patent-ru2841374c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry